Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.

Claudia Richter,Carina Trojahn,Kathrin Hillmann,Gabor Dobos,Andrea Stroux,Jan Kottner,Ulrike Blume-Peytavi

Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.

2016

Claudia Richter
Carina Trojahn
Kathrin Hillmann
Gabor Dobos
Andrea Stroux
Jan Kottner
Ulrike Blume-Peytavi

Background/Aims: Antibiotic-induced drug resistance requires new approaches in topical acne treatment. Tyrothricin is known to produce no resistance. In this stud

Keywords:

Drug resistance
Tyrothricin
Dermatologic agents
Clinical trial
Clindamycin
Dermatology
Acne
Medicine
acne treatment
lesion count
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations